With a more than $2 million price tag, how are payers going to deal with the recently approved Zolgensma?
Asembia offers broad coverage across specialty pharmacy.
Pharmacists are in a unique position to improve orphan drug and precision medicine channels.
Experts offer their thoughts on what the specialty pharmacy industry will look like over the next year.
As the healthcare landscape continues to change at a rapid pace, drug manufacturers need to take a long, hard look at their marketing and commercialization options.
At the 2019 Asembia Specialty Pharmacy Summit, Cardinal Health’s Bruce Feinberg articulates the pros and cons of copay accumulator programs.
The real-world strategies used to manage the high cost of specialty meds.
What health execs need to know about the drugs and policies affecting spending.
What the future of specialty drugs holds for healthcare.
How would you define a specialty pharmaceutical? Chances are, it’s different from the way another healthcare executive would define them.